4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001415889-25-016739
Chief Financial Officer sold 3,300 shares at an average $10.01 ($33,017)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Piscitelli Dominic Chief Financial Officer | 2025-06-10 | Sale 10b5-1 | −324 | $10.00 | $3,240 | 105,093 | D |
| Piscitelli Dominic Chief Financial Officer | 2025-06-11 | Sale 10b5-1 | −1,276 | $10.00 | $12,760 | 103,817 | D |
| Piscitelli Dominic Chief Financial Officer | 2025-06-11 | Sale 10b5-1 | −1,700 | $10.01 | $17,017 | 102,117 | D |
| Open-market sales · 3,300 sh · avg $10.01 · $33,017 | |||||||
Loading xslF345X05/form4-06112025_100647.xml…